Imaging studies may predict tumour response to anti-angiogenic drugs
Advanced imaging techniques may be able to distinguish which patients’ tumours will respond to treatment with anti-angiogenic drugs and which will not. Massachusetts General Hospital (MGH) researchers studied patients newly diagnosed with the dangerous brain tumour glioblastoma and treated with the anti-angiogenic agent cediranib. They report that those patients for whom cediranib rapidly ‘normalised’ abnormal […]